Andrew Davis

Chief Commercial Officer

Andrew Davis brings more than 25 years of experience in the medical device industry, with extensive expertise in commercial leadership and launching innovative therapies that solve unmet clinical needs and increase patient access in cardiovascular diseases. Prior to joining Procyrion, Andy served as Chief Commercial Officer at Silk Road Medical, where he successfully spearheaded the go-to-market strategy for TCAR (TransCarotid Artery Revascularization), a groundbreaking therapy for carotid artery disease, resulting in the company’s acquisition by Boston Scientific. Before Silk Road, he spent 15 years at Medtronic, where he led multiple sales and marketing organizations across Cardiac and Vascular Therapies, including structural heart (TAVR), endovascular (EVAR/TEVAR), peripheral vascular, and spine/biologics. Andy has also held senior commercial roles at Endologix and 3M’s Advanced Wound Therapy Group. He holds a B.S. in Political Science from Florida State University.